This Week’s Top 5: Cancer Screening Breakthroughs Are Bolstering Biotech Stocks, Eli Lilly Gains 14% On Weight-Loss Pill Lead And More

Top 5️⃣ highlights in investing and stock news.

1 The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It. A looming revolution in oncology could help the 18 million cancer survivors in the U.S. and bolster biotech stocks like Guardant Health (GH), Natera (NTRA) and Exact Sciences (EXAS). Read More 2 Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill Read more 3 Inside Palantir AI Strategy: How Forward Deployed Engineers Make A Difference Read more 4 As Apple Sweats, This Partner Warms Up A Breakout — With Caveats Read more 5 Where To Put Money If Treasuries Lose Their Safe-Haven Status Read more Today's Spotlight IBD Digital’s exposure level system helps you avoid market drawdowns––try 2 months for just $12. Subscribe > Learn how IBD responded to the recent market selloff––and how to prepare for the next uptrend.  Register > Which traits do you value most in a financial company? Help shape our survey with your thoughts. Take Survey > ©2025 Investor's Business Daily, LLC. All Rights Reserved. IBD, IBD Digital, IBD Live, IBD Weekly, Investor's Business Daily, Leaderboard, MarketDiem, MarketSurge and other marks are trademarks owned by Investor's Business Daily, LLC. Sent to: indra21poetra@gmail.com Investor's Business Daily, LLC, PO Box 300, Princeton, NJ 08543-0300 Need help? Have feedback? Feel free to contact us Terms of Use | Privacy Notice | Manage Subscriptions | Unsubscribe ID: 7133